RCM
APGN

Rivernorth Capital Management’s Apexigen, Inc. Common Stock APGN Stock Holding History

Rivernorth Capital Management’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-99,998
Closed -$1.01M – 879
2022
Q1 		$1.01M Hold
99,998
– – 0.04% 357
2021
Q4 		$1M Hold
99,998
– – 0.04% 313
2021
Q3 		$995K Hold
99,998
– – 0.05% 252
2021
Q2 		$992K Hold
99,998
– – 0.06% 231
2021
Q1 		$983K Buy
+99,998
New +$1,000K 0.06% 216

Other funds holding APGN

MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

Rivernorth Capital Management's APGN Position: Q2 2022 in Review

Rivernorth Capital Management sold out of Apexigen, Inc. Common Stock (APGN) in Q2 2022, closing a stake of 99,998 shares — an estimated $1.01M sold.

Rivernorth Capital Management first reported a position in APGN in Q1 2021 and held it in 5 quarters. The position peaked at $1.01M in Q1 2022. 27 funds tracked by Wall St. Rank hold APGN as of Q2 2022.

  • Rivernorth Capital Management reported no remaining Apexigen, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Rivernorth Capital Management sold 99,998 Apexigen, Inc. Common Stock shares in Q2 2022, an estimated $1.01M.
  • Rivernorth Capital Management first reported a position in Apexigen, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Rivernorth Capital Management's Apexigen, Inc. Common Stock position peaked at $1.01M in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q2 2022.

Based on Rivernorth Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.